BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25517919)

  • 1. Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines.
    Park SH; Sung JH; Kim EJ; Chung N
    Braz J Med Biol Res; 2015 Feb; 48(2):111-9. PubMed ID: 25517919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of SPARC-enhanced chemosensitivity of pancreatic cancer cells to gemcitabine].
    Zhang J; Jiang H; Mao Z; Wang X; Fan X; Liu Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):335-40. PubMed ID: 25030587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cancer cell growth in gemcitabine-resistant pancreatic carcinoma by mangiferin phytochemical involves induction of autophagy, endogenous ROS production, cell cycle disruption, mitochondrial mediated apoptosis and suppression of cancer cell migration and invasion.
    Yu L; Chen M; Zhang R; Jin Z
    J BUON; 2019; 24(4):1581-1586. PubMed ID: 31646812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G
    Bi YL; Min M; Shen W; Liu Y
    Phytomedicine; 2018 Jan; 39():10-16. PubMed ID: 29433670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2.
    Park SH; Sung JH; Chung N
    Mol Cell Biochem; 2014 Sep; 394(1-2):209-15. PubMed ID: 24894821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabine.
    Yamaguchi M; Murata T; El-Rayes BF; Shoji M
    Oncol Rep; 2015 Dec; 34(6):3304-10. PubMed ID: 26397991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells.
    Mantena SK; Sharma SD; Katiyar SK
    Mol Cancer Ther; 2006 Feb; 5(2):296-308. PubMed ID: 16505103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
    Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
    Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.
    Jiang C; Yi XP; Shen H; Li YX
    World J Gastroenterol; 2012 Jun; 18(23):2956-65. PubMed ID: 22736919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways.
    Li J; Liang X; Yang X
    Oncol Rep; 2012 Aug; 28(2):501-10. PubMed ID: 22641480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression.
    Pandita A; Kumar B; Manvati S; Vaishnavi S; Singh SK; Bamezai RN
    PLoS One; 2014; 9(9):e107154. PubMed ID: 25197966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.
    Zagon IS; Jaglowski JR; Verderame MF; Smith JP; Leure-Dupree AE; McLaughlin PJ
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):510-20. PubMed ID: 15947928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells.
    Wang Y; Zhou Y; Zhou H; Jia G; Liu J; Han B; Cheng Z; Jiang H; Pan S; Sun B
    PLoS One; 2012; 7(8):e43826. PubMed ID: 22952775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piceatannol induces apoptotic cell death through activation of caspase-dependent pathway and upregulation of ROS-mediated mitochondrial dysfunction in pancreatic cancer cells.
    Çınar Ayan İ; Güçlü E; Vural H; Dursun HG
    Mol Biol Rep; 2022 Dec; 49(12):11947-11957. PubMed ID: 36260179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone.
    Prashanth N ; Meghana P ; Sandeep Kumar Jain R ; Pooja S Rajaput ; Satyanarayan N D ; Raja Naika H ; Kumaraswamy H M
    Sci Total Environ; 2024 Mar; 914():169727. PubMed ID: 38163613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine.
    Duong HQ; Hong YB; Kim JS; Lee HS; Yi YW; Kim YJ; Wang A; Zhao W; Cho CH; Seong YS; Bae I
    J Cell Mol Med; 2013 Oct; 17(10):1261-70. PubMed ID: 23855452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells.
    He J; Bugde P; Li J; Biswas R; Li S; Yang X; Tian F; Wu Z; Li Y
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugiol (127horbar;hydroxyabieta-8,11,13-trien-7-one) targets human pancreatic carcinoma cells (Mia-PaCa2) by inducing apoptosis, G2/M cell cycle arrest, ROS production and inhibition of cancer cell migration.
    Hao C; Zhang X; Zhang H; Shang H; Bao J; Wang H; Li Z
    J BUON; 2018; 23(1):205-210. PubMed ID: 29552785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro Study of the Antagonistic Effect of Low-dose Liquiritigenin on Gemcitabine-induced Capillary Leak Syndrome in Pancreatic Adenocarcinoma via Inhibiting ROS- Mediated Signalling Pathways.
    Wu W; Xia Q; Luo RJ; Lin ZQ; Xue P
    Asian Pac J Cancer Prev; 2015; 16(10):4369-76. PubMed ID: 26028101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
    Fujita M; Hasegawa A; Yamamori M; Okamura N
    J Exp Clin Cancer Res; 2017 Jul; 36(1):91. PubMed ID: 28673319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.